logo

For the Inventor, By the Inventor

Westfield, NJ, United States of America

Joung L Goulet

This inventor holds 8 USPTO granted patents, plus 1 CIPO patent. Top assignee: Merck + Co., Inc.. Active years: 1993-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joung L Goulet. Retrieved from https://idiyas.com/inventor/joung-l-goulet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5


Average Co-Inventor Count = 6.0

ph-index = 6

Forward Citations = 372(Granted Patents)


Company Filing History:

goldMedal8 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1993-2005

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 6852727 - Benzimisazo[4,5-f]isoquinolinone derivatives (2005-02-08),
2. 6809199 - (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents (2004-10-26),
3. 6498165 - Src kinase inhibitor compounds (2002-12-24),
4. 6329380 - SRC kinase inhibitor compounds (2001-12-11),
5. 5679700 - Substituted phosphinic acid-containing peptidyl derivatives as (1997-10-21),
6. 5349061 - O-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and (1994-09-20),
7. 5252732 - D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and (1993-10-12),
8. 5208241 - N-heteroaryl, N-alkylheteroaryl, N-alkenylheteroaryl and (1993-05-04),

Title: The Innovative Contributions of Joung L Goulet

Introduction

Joung L Goulet is a prominent inventor based in Westfield, NJ (US), known for her significant contributions to the field of pharmaceuticals. With a total of 8 patents to her name, she has made remarkable strides in developing innovative treatments for various diseases.

Latest Patents

Among her latest patents are the Benzimidazo[4,5-f]isoquinolinone derivatives, which serve as inhibitors of Janus protein tyrosine kinases (Jak). These compounds are particularly useful as immunosuppressants and in the treatment of diseases such as asthma, allergies, and autoimmune disorders. Another notable patent involves (Halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents, which further showcases her expertise in medicinal chemistry.

Career Highlights

Joung L Goulet is currently employed at Merck & Company, Inc., where she continues to push the boundaries of pharmaceutical innovation. Her work has not only contributed to the advancement of medical science but has also positioned her as a key figure in her field.

Collaborations

Throughout her career, Joung has collaborated with esteemed colleagues, including Peter J Sinclair and William H Parsons. These partnerships have enhanced her research and development efforts, leading to groundbreaking discoveries.

Conclusion

Joung L Goulet's innovative work and dedication to advancing medical treatments have made her a significant contributor to the field of pharmaceuticals. Her patents reflect her commitment to improving health outcomes for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…